Understanding the mechanism and the role of inflammation on TMPRSS6 regulation may ultimately lead to new therapeutic strategies to treat diseases where hepcidin levels are deregulated such as β-thalassemia and anemia of chronic disease. Here, HAMP is linked to anemia (phenotype).